Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous guidelines published in the 15 January 2004 issue of Clinical Infectious Diseases and are intended for use by health care providers who care for patients who either have or are at risk of these infections. Since 2004, several new antifungal agents have become available, and several new studies have been published relating to the treatment of candidemia, other forms of invasive candidiasis, and mucosal disease, including oropharyngeal and esophageal candidiasis. There are also recent prospective data on the prevention of invasive candidiasis in high-risk neonates and adults and on the empiric treatment of suspected invasive candidiasis in adults. This new information is incorporated into this revised document.
Pappas
Peter G
PG
Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama 35294-0006, USA. pappas@uab.edu
Kauffman
Carol A
CA
Andes
David
D
Benjamin
Daniel K
DK
Calandra
Thierry F
TF
Edwards
John E
JE
Filler
Scott G
SG
Fisher
John F
JF
Kullberg
Bart-Jan
BJ
Ostrosky-Zeichner
Luis
L
Reboli
Annette C
AC
Rex
John H
JH
Walsh
Thomas J
TJ
Sobel
Jack D
JD
D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000175:diagnosis* / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans
D000935:Antifungal Agents